<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03443778</url>
  </required_header>
  <id_info>
    <org_study_id>907-12.12.2017</org_study_id>
    <nct_id>NCT03443778</nct_id>
  </id_info>
  <brief_title>Dexamethasone-bupivacaine Versus Bupivacaine for Tonsillectomy Pain.</brief_title>
  <official_title>Comparison of Peritonsillar Dexamethasone-bupivacaine and Bupivacaine Infiltration for Tonsillectomy Pain Relief in Children:a Randomized,Double Blind,Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Hamidiye Etfal Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Hamidiye Etfal Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators compared in this study peritonsillar infiltration of bupivacaine %0.5 (n=40
      participants) versus bupivacaine % 0.5 and dexamethasone (number 40participants ) before
      surgery for reduce posttonsillectomy pain.And control group (n= 40participants) participants
      received peritonsillar Nacl 0,9% .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bupivacaine hydrochloride amid structure,long acting local anesthetic. Dexamethasone has
      strong anti-inflammatory drug reduce postoperative pain and nause and vomiting.Preoperative
      iv dexamethasone is routinely using for reduce tonsillectomy pain.Lots of studies show that
      adding dexamethasone to local anesthetic at peripheral nerve block prolongs the analgesic
      effect.Also preoperative iv dexamethasone prolongs the analgesic effects of local anesthetic
      infiltration .

      Post tonsillectomy pain still a serious problem ,it effects postoperative morbidity.Different
      medicine combination used to applies for peritonsillar infiltration and multimodal iv and
      oral medication to reduce posttonsillectomy pain.İn this study investigators will use iv
      dexamethasone for all participants and investigators hypothesis that adding dexamethasone to
      bupivacaine for peritonsillar infiltration will reduce postoperative pain scores ,
      consumption of rescue analgesic ,patient and family satisfaction.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 15, 2017</start_date>
  <completion_date type="Anticipated">April 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of moderate/severe pain(&gt;/= 4 of 10 Pain Scores)</measure>
    <time_frame>postoperative 7day .</time_frame>
    <description>Pain Scores will measure ; Face, Leg, Activity, Cry, Consolability score (FLACC) Interpreting the Score 0 Relaxed &amp; comfortable
1 - 3 = Mild discomfort 4 - 6 = Moderate pain 7 -10 = Severe pain or discomfort or both . 0 score is the best ,10 score is the worse score. 4 and up scores will considered to be the range to be treated .Pain score will measure at home ; Face Pain Scale 0 no pain 10 worse pain. Every day in the morning after phone call pain scores will ask patient/patient guardians. 4 and up scores will treated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects (nause,vomiting)</measure>
    <time_frame>postop seven day</time_frame>
    <description>Nause will measure with visual analog scale (VAS) . 0 is the best 10 is the worse score. vomiting will measure with present/absent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesic consumption at PACU (post-anaesthesia care unit)</measure>
    <time_frame>At Pacu 1 hour</time_frame>
    <description>Pain Scores will measure ; Face, Leg, Activity, Cry, Consolability score (FLACC) Interpreting the Score 0 Relaxed &amp; comfortable
1 - 3 = Mild discomfort 4 - 6 = Moderate pain 7 -10 = Severe pain or discomfort or both . 0 score is the best ,10 score is the worse score. 4 and up scores will considered to be the range to be treated with iv paracetamol (10 mg/kg maximum Daily dosage) . İf the pain score is still 4 and up it will treated with tramadol 1 mg/kg).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesic consumption first day at hospital</measure>
    <time_frame>4,8,12,24 h at hospital in first postoperative day.</time_frame>
    <description>Pain Scores will measure ; Face, Leg, Activity, Cry, Consolability score (FLACC) Interpreting the Score 0 Relaxed &amp; comfortable
1 - 3 = Mild discomfort 4 - 6 = Moderate pain 7 -10 = Severe pain or discomfort or both . 0 score is the best ,10 score is the worse score. 4 and up scores will treated with oral paracetamol (10 mg/kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesic consumption at home</measure>
    <time_frame>postop 2-3-5-6- 7. day</time_frame>
    <description>Pain Scores will measure ; Face Pain Scale 0 no pain 10 worse pain. 4 and up scores will treated with oral paracetamol (10 mg/kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parents satisfaction</measure>
    <time_frame>postop seven day</time_frame>
    <description>Parents satisfaction will measure visual analog scale (VAS) . 0 is the best 10 is the worse score.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Tonsillectomy</condition>
  <arm_group>
    <arm_group_label>Nacl 0,9% (Control) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nacl 0,9% 3-5 ml separately two part for each tonsil before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 0.5% 1 mg/kg with in Nacl 0,9% 3-5 ml separately two part for each tonsil before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine 0,5% , Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 0,5% 1 mg/kg,dexamethasone 0.5 mg/kg (max dosage 8mg) 3-5 ml separately two part for each tonsil before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.5%</intervention_name>
    <description>Marcaine 0.5% Injectable Solution</description>
    <arm_group_label>Bupivacaine 0,5%</arm_group_label>
    <other_name>Marcaine 0,5%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.5% , Dexamethasone</intervention_name>
    <description>Bupivacaine 0.5% , Dexamethasone</description>
    <arm_group_label>Bupivacaine 0,5% , Dexamethasone</arm_group_label>
    <other_name>Dekort</other_name>
    <other_name>Marcaine 0,5 % Injectable Solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nacl 0,9 %</intervention_name>
    <description>Injectable Solution</description>
    <arm_group_label>Nacl 0,9% (Control) group</arm_group_label>
    <other_name>Serum Physiologic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Tonsillectomy surgery for recurrent tonsillitis Sleep disorder breathing

        ExclusionCriteria:

        Patients with active upper respiratory tract infection Patients with significant cognitive
        impairment Bupivacaine hypersensitivity Dexamethasone hypersensitivity Taking chronic
        systemic steroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leyla Kilinc, Md</last_name>
    <role>Study Director</role>
    <affiliation>Md</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Leyla Kilinc</name>
      <address>
        <city>İstanbul</city>
        <state>Sisli</state>
        <zip>34360</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Bayram A, Doğan M, Cihan C, Karataş D, Gökahmetoğlu G, Özcan I. The Efficacy of Levobupivacaine Hydrochloride-Dexamethasone Infiltration for Post-Tonsillectomy Pain in Adults. J Craniofac Surg. 2015 Oct;26(7):e651-3. doi: 10.1097/SCS.0000000000001975.</citation>
    <PMID>26468853</PMID>
  </reference>
  <reference>
    <citation>Basuni AS, Ezz HA, Albirmawy OA. Preoperative peritonsillar infiltration of dexamethasone and levobupivacaine reduces pediatric post-tonsillectomy pain: a double-blind prospective randomized clinical trial. J Anesth. 2013 Dec;27(6):844-9. doi: 10.1007/s00540-013-1638-0. Epub 2013 May 25.</citation>
    <PMID>23708881</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2017</study_first_submitted>
  <study_first_submitted_qc>February 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2018</study_first_posted>
  <last_update_submitted>February 21, 2018</last_update_submitted>
  <last_update_submitted_qc>February 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Hamidiye Etfal Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Leyla Kılınc</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>tonsillectomy pain</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>bupivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant (IPD) to the other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

